🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ami V. Desai

University of Illinois Chicago

ORCID: 0000-0001-9658-3156

Also affiliated with University of Chicago

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Outcomes and toxicities in patients (pts) non-randomly assigned to immunotherapy Children’s Oncology Group (COG) ANBL0032.”.

Outcomes and toxicities in patients (pts) non-randomly assigned to immunotherapy Children’s Oncology Group (COG) ANBL0032.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10523
N/A
0DataRank · unranked
0 citations

Andrew L. Gilman, M. Fevzi Özkaynak, Arlene Naranjo, Wendy B. London, Sheena C. Tenney +11 more

Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002417
N/A
0DataRank · unranked
46 citations

Stefani Spranger, Kyle M. Hernandez, Yuanyuan Zha, Peter Pytel, Jason J. Luke +5 more

Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease

Cancer(2022)10.1002/cncr.34263
N/A
0DataRank · unranked
13 citations

Mark A. Applebaum, Theodore Karrison, Akosua Y. Oppong, Cindy Yuan, Katherine R. Berg +14 more

Phase I trial of lorlatinib in combination with topotecan/cyclophosphamide in children with ALK-driven refractory or relapsed neuroblastoma: A new approaches to neuroblastoma therapy consortium study.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10041
N/A
0DataRank · unranked
0 citations

Yaël P. Mossé, Kimberly Kayser, Yueh‐Yun Chi, Marc Chioda, Holger Thurm +14 more

T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signature

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.26.546541
N/A
0DataRank · unranked
2 citations

Omar R. Vayani, Kelley Moore, Alexandre Chlenski, Tong Wu, Gepoliano Chavez +6 more

Healthcare utilization disparities among children with high‐risk neuroblastoma treated on Children's Oncology Group clinical trials

Pediatric Blood & Cancer(2024)10.1002/pbc.31192
N/A
0DataRank · unranked
0 citations

Yimei Li, Kelly Getz, Yuan‐Shung Huang, Matt Hall, Arlene Naranjo +12 more